Last reviewed · How we verify
Cholecalciferol high dose at Vitamin D deficiency
At a glance
| Generic name | Cholecalciferol high dose at Vitamin D deficiency |
|---|---|
| Also known as | Vigantol Oil 20 000 IU/ml, drops for oral use, solution |
| Sponsor | Umeå University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease (PHASE2)
- High-Dose vs Standard Ergocalciferol for Vitamin D Normalization in Aggressive Non-Hodgkin Lymphoma (NA)
- Vitamin D Deficiency in Adults Following a Major Burn Injury (PHASE4)
- Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover (PHASE4)
- Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients
- Vitamin Deficiency in Immigrants, a Treatment Study (PHASE4)
- Effect of Vitamin D Status and Repletion on Postoperative Total Joint Arthroplasty Complications (NA)
- Effect of Preoperative High-dose Cholecalciferol in Prevention of Post-thyroidectomy Hypocalcaemia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: